Trials / Conditions / Disseminated Neuroblastoma

Disseminated Neuroblastoma

17 registered clinical trials studyying Disseminated Neuroblastoma.

Status	Trial	Sponsor	Phase
Unknown	Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteo NCT02173093	University of Virginia	Phase 1 / Phase 2
Withdrawn	Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant NCT01558778	Roswell Park Cancer Institute	N/A
Completed	Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma NCT01358617	Children's Oncology Group	—
Completed	Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or NCT01305200	Children's Oncology Group	Phase 3
Completed	Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia NCT01484015	Wake Forest University Health Sciences	Phase 1
Terminated	Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload NCT01159067	City of Hope Medical Center	Phase 2
Completed	Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant NCT00795769	Fred Hutchinson Cancer Center	Phase 2
Completed	Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors NCT00799461	Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Phase 3
Completed	Study of DNA in Blood Samples From Patients With Neuroblastoma NCT00898391	Children's Oncology Group	—
Completed	ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment NCT00436852	Children's Oncology Group	Phase 2
Completed	Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem NCT00408681	Fred Hutchinson Cancer Center	N/A
Completed	Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Tr NCT00309907	Children's Oncology Group	Phase 2
Completed	Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors NCT00093821	National Cancer Institute (NCI)	Phase 1
Completed	Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer NCT00060372	National Cancer Institute (NCI)	Phase 1
Terminated	Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neurob NCT00053950	National Cancer Institute (NCI)	Phase 1
Completed	R(+)XK469 in Treating Patients With Advanced Neuroblastoma NCT00028522	National Cancer Institute (NCI)	Phase 1
Completed	Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma NCT00005576	National Cancer Institute (NCI)	Phase 1